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Background: Circulating neopterin and the ratio of kynurenine to tryptophan (KYN/TRP) concentrations are bio-
markers of immune activation that have been linked to cardiovascular and totalmortality. Several in vitro studies
indicated that tea ﬂavonoids and other antioxidants can modulate tryptophan breakdown rates and neopterin
production in immune cells. We aimed to assess the effects of regular black tea consumption on tryptophan
and neopterin metabolisms in vivo.
Methods: Participants were healthy individuals, with no major illnesses and having normal to mildly elevated
systolic blood pressure. Theywere randomly assigned to consume 3 cups/day of either powdered black tea solids
(tea; n = 45) or a ﬂavonoid-free caffeine-matched beverage (control; n = 49). Serum concentrations of trypto-
phan, kynurenine and neopterin were assessed at baseline and again at 3 and 6 months after daily ingestion of
the respective beverage.
Results: Regular consumption of tea over 6 months, compared to control, did not signiﬁcantly alter neopterin
(p = 0.13) or tryptophan (p = 0.85) concentrations, but did result in signiﬁcantly higher kynurenine
(p = 0.016) and KYN/TRP (p = 0.012). Relative to the control group, in the tea group kynurenine and
KYN/TRP increased during the treatment period by 0.28 μmol/L (95% CI: −0.04, 0.60) and 3.2 μmol/mmol
(95% CI: −1.6, 8.0), respectively at 3 months, and by 0.48 μmol/L (95% CI: 0.16, 0.80) and 7.5 μmol/mmol
(95% CI: 2.5, 12.5), respectively at 6 months.
Conclusions: Increased circulation of kynurenine and KYN/TRP following regular black tea consumptionmay
indicate enhanced tryptophan breakdown, possibly due to immune activation-induced tryptophan
degrading enzyme indoleamine 2,3-dioxygenase.
General signiﬁcance: The inﬂuence of black tea consumption on biomarkers of immune system activation
could relate to its general health beneﬁts. Data suggests that the net effect strongly depends on the individ-
ual immune state, being stimulatory in healthy individuals, while acting more immune dampening in situ-
ations with an inﬂammatory background.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Inﬂammation and immune activation play key roles in the patho-
genesis of atherosclerosis [1,2]. This is reﬂected by an increase of inﬂam-
matory cells, such as activated macrophages, and high level production
of pro-inﬂammatory cytokines in the atherosclerotic plaque. In the cir-
culation, the inﬂammatory processmanifests in elevated concentrationsland Clinical Trials Registry as
hemistry, Biocenter, Medical
ria. Tel.: +43 512 9003 70350;
. This is an open access article underof pro-inﬂammatory biomarkers such as interleukin-6, C-reactive pro-
tein and serum amyloid A [1,2]. Likewise, the macrophage product
neopterin is formed and enhanced tryptophan breakdown is detectable
by an increased kynurenine to tryptophan ratio (KYN/TRP) [3,4]. Both
neopterin production and tryptophan breakdown are related to inﬂam-
mation where increased formation of Th1-type cytokine interferon-γ
(IFN-γ) activates neopterin production via GTP-cyclohydrolase I and in-
duces tryptophan-degrading enzyme indoleamine 2,3-dioxygenase
(IDO). Many inﬂammation-induced biomarkers have been found to
strongly predict disease speciﬁc outcome and overall mortality in pa-
tients suffering from cardiovascular disease (CVD). Neopterin produc-
tion and tryptophan breakdown may be among the most sensitive
predictors of prognosis in such patients [4].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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compounds like lycopene and lutein are reduced in patients suffering
from inﬂammatory conditions such as CVD [5,6]. Moreover, there is ev-
idence for a relationship between a higher degree of inﬂammation and
immune activation and a lower vitamin status [7]. Dietary interventions
are thought to be of value to slow-down inﬂammation. A diet rich in
antioxidants and antioxidant supplements may provide beneﬁt on
cardiovascular outcomes [8,9]. In addition, a positive inﬂuence of
Mediterranean diet supplemented with extra-virgin olive oil or nuts
was demonstrated among persons at high cardiovascular risk [10]. A
2-year intervention trial involving healthy dietary changes had long-
lasting, favorable post-intervention effects, particularly among partici-
pants receiving the Mediterranean and low-carbohydrate diets [11].
However, any positive inﬂuence of pure supplemented antioxidants
like vitamins still remains to be demonstrated.
There is increasing evidence that beverages rich in antioxidant poly-
phenols like tea, cacao and red wine, could provide a positive inﬂuence
on cardiovascular health. We recently reported that black tea can affect
blood pressure beneﬁcially [12,13]. Interestingly, antioxidant com-
pounds and extracts of antioxidant-rich beverages such as tea were ob-
served to suppress immune activation cascades, pro-inﬂammatory
cytokines, neopterin and tryptophan breakdown in mitogen-stimulated
human peripheral blood mononuclear cells (PBMC) in vitro [14]. These
effects appear to be sharedwith other compounds and extracts prepared
from plants and fruits with suggested anti-inﬂammatory and/or antioxi-
dant properties like salicylic acid [14], resveratrol [15] and cannabinoids
[14], black tea [16], wine [17], cacao [14] and coffee [18]. For the effect of
black tea, ﬂavonoid compounds are considered to be of importance [13,
15,19]. However, in resting immune cells, the effects of compounds like
resveratrol or beverages like wine or tea were found to be stimulatory
rather than immunosuppressive [12,13]. Thus, results from in vitro stud-
ies only provide a limited picture.
We have previously reported the results from the primary outcome
of the present study demonstrating that regular ingestion of black tea
results in lower blood pressure and lower blood pressure variation
[13]. Recently, kynurenine was shown to mediate vasorelaxation and
lower blood pressure [19]. Thus, the objective of the current analysis
was to assess the effects of longer-term regular consumption of black
tea, over 6months, on neopterin formation and tryptophanmetabolism
in healthy individualswithmild tomoderate elevations in systolic blood
pressure. We have also explored the relationships of any change in
kynurenine concentrations with observed changes in blood pressure.
2. Subjects and methods
2.1. Study subjects
Volunteers were recruited from the general population of Perth,
Australia, by using print media advertisements. Participants were tea
drinkers, aged 35–75 years, had BMI of 19–35 kg/m2, were non-
diabetic, had not taken nutritional supplements or antibiotics from 4
weeks before beginning the trial, and had no major illness [13]. The
trial was approved by the University of Western Australia Ethics Com-
mittee and registered at the Australian New Zealand Clinical trials Reg-
istry as ACTR12607000543482. Procedures followedwere in accordance
with institutional guidelines.
2.2. Study design
A randomized, controlled, double-blind, 6-month parallel-designed
intervention study was performed [13]. The 6-month intervention was
precededby a 4-week run-in periodduringwhich participants consumed
3 cups of regular leaf tea each day prepared in the usual manner. During
the fourth week of the run-in period, participants attended the School of
Medicine and Pharmacology research unit located at Royal Perth Hospi-
tal, where all baseline measurements were performed. During the 6-month intervention period, participants consumed 3 cups/day of either
powdered black tea solids, which supplied 429 mg total polyphenols
(primarily ﬂavonoids)/day and 96 mg caffeine (tea)/day or a ﬂavor-
matched, ﬂavonoid-free, and caffeine-matched placebo (control). Partic-
ipants were advised to consume tea or control products at the time that
they would normally consume tea. For further details see ref. [13].
After random assignment, participants were required to follow a
low-ﬂavonoid diet throughout the trial. Apart from the prescribed tea
intake, participants did not consume any additional tea, they did not
consume dark chocolate or red wine, the intake of fruit juices was lim-
ited to b4 glasses/week, and coffee intake was limited to b1 cup/day
on average (b7 cups/week). A dietitian monitored each participant's
progress every 4 weeks to ensure compliance. Participants were
instructed to add the contents of a sachet of powdered tea solids or
placebo to ~200mL boiled hotwater and stir the solution until the pow-
der completely dissolved. The addition of sugar,milk, creamor other ad-
ditives was not allowed, and the product was consumed while still hot.
2.3. Laboratory measurements and blood pressure assessment
The 24 h 4-O-methylgallic acid (4OMGA) excretion was used as a
biomarker of black tea intake and black tea-derived ﬂavonoid exposure
and to assess compliance [13]. To monitor immune activation status of
study participants, free serum concentrations of tryptophan and
kynureninewere determined byhigh-performance liquid chromatogra-
phy, as described elsewhere [20]. KYN/TRPwas calculated as an index of
tryptophan breakdown [20]. Serum neopterin concentrations were
measured by commercially available enzyme-linked immunosorbent
assay (BRAHMS Diagnostics, Hennigsdorf, Germany). The 24 h ambula-
tory blood pressure (BP) wasmeasured as previously described [12,13].
2.4. Statistical analysis
The sample size for this study was based on the primary outcome of
24-h ambulatory systolic BP. We estimated that 100 participants (50
participants/group) would provide 90% power at two-tailed α= 0.05
to detect a difference of 3 mm Hg in 24-h systolic BP. Results of the pri-
mary outcome of the study (i.e., BP) have been published [12]. Collec-
tion of blood samples during the study allowed investigation of the
effects of tea on tryptophan and neopterin metabolisms by measuring
circulating concentrations of kynurenine, tryptophan and neopterin.
Post-hoc analysis of study power indicated that we had more than
80% power to detect a 1.4 nmol/L difference in neopterin and a 0.45
μmol/L difference in kynurenine.
Descriptive statistics are presented as means± SDs. Categorical var-
iables were summarized by number in each category. A two-tailed type-
1 error rate of p b 0.05 was the level of signiﬁcance used for all hypoth-
esis testing. At baseline, characteristics of participants in the 2 groups
were compared by using the independent-samples t test on transformed
data, when appropriate, and the chi-square test for categorical variables.
Spearman's rank correlation coefﬁcient was used to explore the degree
and direction of associations of neopterin, kynurenine and KYN/TRP
with traditional cardiovascular disease risk factors at baseline. Baseline,
3- and 6-month values for outcome measures and between-group dif-
ferences are presented as least-squares means and 95% CIs. The primary
analysis was a modiﬁed intent-to-treat analysis with the population de-
ﬁned as participants who were randomly assigned to the study for
which there were complete baseline measurements of neopterin,
kynurenine and tryptophan (n = 94). Outcomes were analyzed by
using mixed models in SAS software (version 9.3; SAS Institute Inc.).
The PROC MIXED command of the SAS program was used to determine
the effect of tea comparedwith the control. Fixed effects in themodel in-
cluded time (baseline, 3 and 6months;modeled as 3 separate binary in-
dicator variables), treatment group (tea and control), and treatment
group× time (inwhich timewasmodeled as 3 separate binary indicator
variables). The overall effect of treatment was established by using the
Table 1
Baseline characteristics of the participants in the control and tea groups.a
Control (n = 49) Tea (n = 45)
Gender (M/F) 18/31 15/30
Age (year) 56.3 (10.6)b 57.1 (10.8)
Body mass index (kg/m2) 25.2 (3.3) 24.8 (3.6)
Waist circumference (cm) 82 (12) 82 (11)
33J.M. Gostner et al. / BBA Clinical 3 (2015) 31–35global treatment group× time interaction term.Differences between the
tea and control were also assessed and reported individually at 3 and 6
months. Pearson's correlation coefﬁcient was used to explore the degree
and direction of associations of the change in neopterin, kynurenine and
KYN/TRP from baseline to 6 months (6 months–baseline) with the
change in 4OMGA from baseline to 6 months and the change in blood
pressure from baseline to 6 months.Total cholesterol (mmol/L) 5.2 (1.0) 5.1 (0.8)
Glucose (mmol/L) 5.1 (0.5) 5.2 (0.8)
Ofﬁce systolic blood pressure (mm Hg) 119 (14) 122 (14)
Ofﬁce diastolic blood pressure (mm Hg) 70 (7) 69 (7)
a Intent-to-treat population included 94 participants; characteristics were not different
between groups at baseline (p N 0.05 for between-group differences analyzed using inde-
pendent samples t-test and the chi-square test for categorical variables).
b Mean (SD) for all such values.3. Results
3.1. Descriptive and baseline data
The study was performed between October 2007 and September
2010. Ninety-four participants had complete neopterin, kynurenine
and tryptophan measurements available at baseline (Fig. 1). Baseline
characteristics of the participants are presented in Table 1. Neopterin,
kynurenine, tryptophan and KYN/TRP values at baseline, 3 months
and 6 months are presented in Table 2.
At baseline, neopterin was positively associated with kynurenine
(r = 0.22, p = 0.03) and KYN/TRP (r = 0.37, p b 0.001). In addition,
during the intervention, at both 3 and 6 months signiﬁcant correla-
tions existed between neopterin and KYN/TRP in the controls (at
3 months: r = 0.50, p b 0.001; at 6 months: r = 0.48, p b 0.001) and
in the tea group (at 3 months: r = 0.51, p b 0.001; at 6 months:
r = 0.50, p b 0.001). Neopterin concentrations at baseline were pos-
itively associatedwith age (r= 0.28, p=0.007), but there existed no
other signiﬁcant relationships. Kynurenine concentrations at
baseline were positively associated with age (r = 0.28, p = 0.007),
waist circumference (r = 0.32, p = 0.002) and fasting glucose
(r = 0.25, p = 0.02). The baseline KYN/TRP ratio was positively as-
sociated with age (r = 0.32, p= 0.002), body mass index (r = 0.25,
p = 0.02), waist circumference (r = 0.28, p = 0.006) and fasting
glucose (r = 0.21, p = 0.05).Fig. 1. Participants at each stage of the trial.3.2. Effects on neopterin, kynurenine and tryptophan metabolisms
Regular consumption of tea compared to control did not signiﬁcant-
ly alter neopterin concentrations over the 6 month intervention period
(p = 0.13 for global treatment × time interaction; Fig. 2, upper). At 3
months, the difference between groups was 0.7 nmol/L (95% CI:−0.5,
1.9) (p = 0.27); and at 6 months the difference was 1.3 nmol/L (95%
CI: 0.1, 2.5) (p=0.03). Regular consumption of tea compared to control
resulted in a signiﬁcant difference in kynurenine (p= 0.016 for global
treatment× time interaction; Fig. 2, middle). At 3months the difference
between groups was 0.28 μmol/L (95% CI:−0.04, 0.60) (p = 0.083);
and at 6 months the difference was 0.48 μmol/L (95% CI: 0.16, 0.80)
(p=0.004). Consumption of tea relative to control also resulted in a sig-
niﬁcant difference in KYN/TRP (p= 0.012 for global treatment × time
interaction; Fig. 2, lower). At 3 months the difference between groups
was 3.2 μmol/L (95% CI:−1.6, 8.0) (p=0.18); and at 6 months the dif-
ference was 7.5 μmol/L (95% CI: 2.5, 12.5) (p= 0.003). Adjustment for
age, body mass index, waist circumference and fasting glucose concen-
trations did not alter the observed effects on kynurenine or KYN/TRP
(data not presented). Tryptophan concentrations over the 6 month in-
tervention period were not altered (p= 0.85).Table 2









Baseline 6.9 (3.6)b 5.5 (1.7)
3 months 6.4 (2.7) 5.6 (1.9) 0.7 (−0.5, 1.9)a 0.27
6 months 5.8 (2.0) 5.7 (3.3) 1.3 (0.1, 2.5) 0.03




Baseline 68 (11) 70 (10)
3 months 68 (11) 71 (12) 1.2 (−1.4, 5.6) 0.57
6 months 69 (13) 71 (11) 0.6 (−3.8, 5.0) 0.79




Baseline 3.2 (0.9) 2.9 (0.7)
3 months 3.1 (0.9) 3.1 (0.7) 0.28 (−0.04, 0.60) 0.083
6 months 3.1 (1.0) 3.4 (0.8) 0.48 (0.16, 0.80) 0.004




Baseline 47 (12) 42 (9)
3 months 46 (12) 44 (9) 3.2 (−1.6, 8.0) 0.18
6 months 45 (12) 49 (14) 7.5 (2.5, 12.5) 0.003
Global treatment × time
interaction
0.012
a Least squares mean difference.
b Observed mean values and SD in brackets.
Fig. 2. Serum concentrations (mean±SD) of neopterin (upper), kynurenine (middle) and
kynurenine to tryptophan ratio (KYN/TRP) (lower) in individuals exposed to tea during 6
months (p-values for treatment by time interactions). Participants consumed 3 cups/day
of either powdered black tea solids (red lines) or a ﬂavonoid-free caffeine-matched bever-
age (blue lines).
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exposure) from baseline to 6 months (6 months–baseline) was pos-
itively correlated with change (6 months–baseline) in kynurenine
(r = 0.31, p = 0.008) and KYN/TRP (r = 0.30, p = 0.01) but not
neopterin (r = 0.13, p= 0.28). In addition, the change in 24-h systolic
and diastolic blood pressure (6 months–baseline) was negatively
correlated with the change (6 months–baseline) in neopterin (systolic:
r = −0.26, p = 0.03; diastolic: r = −0.31, p = 0.006), kynurenine
(systolic r = −0.20, p = 0.08; diastolic: r = −0.21, p = 0.06) and
KYN/TRP (systolic: r=−0.26, p=0.02; diastolic r=−0.23, p=0.04).4. Discussion
Our study revealed that black tea consumption in comparison to a
caffeine-matched control beverage may increase serum concentrations
of immunobiochemical markers of tryptophan metabolism. Both
kynurenine and KYN/TRP were signiﬁcantly increased with tea over
the 6 month intervention, with the largest increases observed at the 6
month time point with tea compared to control. Although a similar
trend for neopterin was found and the difference in changes from base-
line at 6 months was signiﬁcant, there was no overall signiﬁcant differ-
ence between group changes over the 6 month intervention.Black and green tea extracts and related polyphenols were shown to
exert suppressive effects on neopterin and cytokine production and on
KYN/TRP in vitro [14-16]. Thus, the increase of kynurenine concentra-
tions in the tea group is unexpected at ﬁrst glance, because a
cardioprotective activity of black tea is considered in part to be due to
anti-inﬂammatory and immunosuppressive properties [21–23]. How-
ever, in the in vitro studies, the immunosuppressive properties were ob-
served in PBMC that were pre-stimulated with mitogens such as
phytohemagglutinin or concanavalin A. In contrast, therewas a stimula-
tory effect of extracts on resting PBMC [15,16]. Thus, the ﬁndings of the
present study that black tea consumptionmay induce neopterin forma-
tion and kynurenine production due to accelerated tryptophan break-
down are in line with the observations derived from in vitro studies
using resting PBMC. This may be more representative of what occurs
in healthy individuals, while the suppression of stimulated PBMC may
reﬂect processes that occur in individuals with an activated immune
system. Interestingly, both anti- and pro-oxidant properties have been
reported for green tea catechins [12,24–26]. Induction of ROS due to su-
peroxide formation by catechin in the presence of oxygen and transition
metals is an important property for its bioactivity as phytotoxin [26], but
also for its chemopreventive effects [27]. Thus, these bidirectional ef-
fects could help to explain why black tea is associated with reduced
risk of CVD. Thismay involve both enhancing activation status of immu-
nocompetent cells leading to increased immune surveillance and
inhibiting low grade inﬂammation.
The correlations found between the kynurenine and KYN/TRP con-
centrations and the concentrations of immune activation marker
neopterin suggest that they are associated with increased immune acti-
vation and inﬂammation. Thus, the observed association between
kynurenine metabolism (KYN/TRP) and neopterin concentrations
throughout the study in both groups suggests an involvement of en-
zyme indoleamine 2,3-dioxygenase (IDO) rather than liver enzyme
tryptophan 2,3-dioxygenase (TDO) in the alterations of kynurenine
concentrations. TDO is primarily controlled by tryptophan concentra-
tions but independent from immunological stimuli. However, the asso-
ciation between neopterin and kynurenine levels indicates an induction
of pro-inﬂammatory cytokine cascades in study participants to be re-
sponsible for the induction of IDO and the increase of kynurenine. We
speculate that the inﬂuence of black tea on kynurenine concentrations
was due to the induction of pro-inﬂammatory cytokines like IFN-γ.
This may support protection of the human organism from infection
and even malignant development in an antiproliferative milieu, which
is achieved by the induction of IFN-γ-dependent effector pathways.
It is possible that the situation might be different in patients that
are already suffering from inﬂammatory diseases and thus height-
ened oxidative stress. Our ﬁndings in healthy individuals may not
be extrapolated to those suffering from CVD, infections or malignant
diseases.
The observed increase of kynurenine and KYN/TRP concentrations
might also relate to the inﬂuence of black tea to lower blood pressure
and its beneﬁt for cardiovascular health [21-23,27-30]. In rats adminis-
tration of kynurenine was demonstrated to beneﬁcially inﬂuence blood
pressure. In the current study we observed a negative correlation be-
tween the change in kynurenine and the change in blood pressure
from baseline to 6 months. Thus, the increase of kynurenine levels in
the tea group in our studymay be linked to the blood pressure lowering
during black tea consumption, which was described earlier [19,29].
Of note, at baseline, signiﬁcant associationswere found for kynurenine
with parameters such as waist circumference and fasting glucose, as well
as for KYN/TRP with age, body mass index, waist circumference and
fasting glucose. Given the close crosstalk between metabolism and im-
mune response, also these associations indicate an individual's immune
status. An association of neopterin levels with age and immune status
has been documented earlier [31]
In conclusion, our study shows that black tea consumption is associ-
ated with an increased kynurenine production in individuals with no
35J.M. Gostner et al. / BBA Clinical 3 (2015) 31–35major illnesses and having normal to mildly elevated systolic blood
pressure. It may partly relate to the positive inﬂuence of black tea on
blood pressure in our study participants, and it is suggested to relate
to activation of IDO. In turn, activated IDO could contribute to slowing
down of immune activation and inﬂammation.
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